… a serious pneumonia event, defined as a first hospitalisation for or death from pneumonia. A
… estimate the rate ratio (RR) of serious pneumonia associated with current ICS use, adjusted …

… between pneumonia and the use of inhaled corticosteroids. We … risk of pneumonia with
long-term inhaled corticosteroid use … of serious pneumonia associated with inhaled corticosteroid …

… and adverse effects of inhaled corticosteroids in individuals with … of increased pneumonia
risk with inhaled corticosteroids is … Inhaled corticosteroids in COPD and the risk of serious …

… ICSs were associated with a significantly increased risk of serious pneumonia when
compared with placebo (RR, 1.81; 95% CI: 1.44 – 2.29, p < 0.001) or when the combination of …

… relative effect of ICS on pneumonia adverse events (AEs) or serious adverse events (SAEs). …
The use of inhaled corticosteroids has been associated with an increased risk of pneumonia …

… Inhaled corticosteroids (ICS) are drugs that can reduce the occurrence of COPD flare‐ups
and … We primarily looked at pneumonia events leading to hospital admissions (ie serious …

… ); 62 cases of pneumonia were reported as either an adverse or a serious adverse event
for budesonide compared with 82 for the comparator. In the primary dataset, the rate of …

… of nonfatal serious pneumonia events … serious, community-managed pneumonia events
with FP compared with BUD, with no significant differences with respect to serious pneumonia …

… are among the most frequent causes of death, and as such the overall mortality would be
expected to be higher in a group of COPD patients with higher rates of serious pneumonia. …

… populations, especially as it relates to serious pneumonias that require hospitalization. Those
… diagnosed COPD patients is associated with an increased risk of serious pneumonias. …